People | 10 January 2023
GenNext Technologies appoints Dr. John Grant to its Board of Directors
Dr. Grant brings to the table significant BOD governance, global business development, and corporate development expertise
Dr. Grant brings to the table significant BOD governance, global business development, and corporate development expertise
Dr. Jain is a biotechnology industry veteran with more than two decades of experience in pharmaceutical development across her time with ChemoCentryx, AbbVie, Abbott Laboratories, and G.D. Searle and Co
Honan will lead the company in identifying and executing acquisitions that complement Emmes’ existing strong federal government client base, expand its biopharma portfolio, enhance its technology offerings, and broaden its global reach
Over 30 years of deep life sciences industry experience with a wide range of expertise in corporate governance, capital markets, licensing and strategic collaborations
Surana is a chartered accountant with an all-India rank.
He has published more than 100 research papers in several prestigious national and international journals
Allam was serving recently as the CEO at Public Investment Fund
Her previous role at Novartis, where she was general manager, data & digital, in global drug development, also included accountability for driving the DCT strategy, programs and platforms
Sanjeev is currently the Country President for AstraZeneca Malaysia
He has global experience in strategic and operational leadership including at Board, CEO and Senior Corporate levels
He is a seasoned leader with 34 years of rich and diverse experience across geographies and consumer facing companies such as Xerox India and Bharti Airtel
Spiro will be responsible for the overall strategy, implementation and growth of Lupin’s U.S. Generics business
Tambe has been with Biocon since 1997 and has held diverse leadership and operational roles.
The company is in the process of appointing a new CFO.
Steve joins Sai Life Sciences from GlaxoSmithKline (GSK) where he was a department head and member of the global chemical development leadership team.
She will provide strategic advice and scientific leadership to support clients in clinical development, registration strategy, submission, early post-approval strategy
He brings over 30 years of experience across various organizations such as Asian Paints PPG, Berger Paints, Tata Steel, among others
Reinforcing GLC’s commitment to sustainable processing in pharmaceutical chemistry
Viehbacher brings extensive international experience in large pharmaceutical and entrepreneurial biotech companies
His experience covers a wide range of areas including advisory services in the field of accounting, taxation, corporate and commercial laws, and regulatory matters
Subscribe To Our Newsletter & Stay Updated
